共 69 条
[1]
Aylward G.W., Progressive changes in diabetics and their management, Eye, 19, 10, pp. 1115-1118, (2005)
[2]
Wild S., Roglic G., Green A., Sicree R., King H., Global prevalence of diabetes, Diabetes Care, 27, pp. 1047-1053, (2004)
[3]
Aronson D., Hyperglycemia and pathobiology of diabetic complications, Adv Cardiol, 45, pp. 1-16, (2008)
[4]
Harrison D., Griendling K.K., Landmesser U., Hornig B., Drexler H., Role of oxidative stress in atherosclerosis, Am J Cardiol, 91, 3 A, (2003)
[5]
Dash D., Shrivastava S., Applying Nanotechnology to Human Health: Revolution in Biomedical Sciences, J Nanotechnology
[6]
Norton S., A brief history of potable gold, Mol Interv, 8, 3, pp. 120-125, (2008)
[7]
Jeon K.I., Byun M.S., Jue D.M., Gold compound auranofin inhibits Ikappa B kinase (IKK) by modifying Cys-179 of IKKbeta subunit, Exp Mol Med, 35, pp. 61-66, (2003)
[8]
Kim N.H., Lee M.Y., Park S.J., Choi J.S., Oh M.K., Kim I.S., Auranofin blocks interleukin-6 signalling by inhibiting phosphorylation of JAK1 and STAT3, Immunology, 122, pp. 607-614, (2007)
[9]
Shah Z.A., Vohora S.B., Antioxidant/Restorative Effects of Calcined Gold Preparations Used in Indian Systems of Medicine against Global and Focal Models of Ischaemia, Pharmacol Toxicol, 90, pp. 254-259, (2002)
[10]
Kalishwaralal K., Deepak V., Pandian S.R.K., Gurunathan S., Biological synthesis of gold nanocubes using Bacillus licheniformis, Bioresour Technol, 100, pp. 5356-5358, (2009)